Correction to "Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (S)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one, by Fragment-Based Drug Design".
J Med Chem
; 64(21): 16318, 2021 Nov 11.
Article
in En
| MEDLINE
| ID: mdl-34708652
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Med Chem
Year:
2021
Document type:
Article